Last $0.16 USD
Change Today -0.0258 / -13.74%
Volume 49.2K
KLYG On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

kelyniam global inc (KLYG) Snapshot

Open
$0.16
Previous Close
$0.19
Day High
$0.16
Day Low
$0.16
52 Week High
06/3/14 - $0.25
52 Week Low
09/12/13 - $0.10
Market Cap
2.6M
Average Volume 10 Days
9.8K
EPS TTM
--
Shares Outstanding
16.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KELYNIAM GLOBAL INC (KLYG)

Related News

No related news articles were found.

kelyniam global inc (KLYG) Related Businessweek News

No Related Businessweek News Found

kelyniam global inc (KLYG) Details

Kelyniam Global, Inc., a medical device manufacturing company, produces custom prosthetics utilizing computer aided design and computer aided manufacturing of medical grade polymers. The company provides replicated cranial implants to replace damaged bone structures. It also offers precision prototypes and computer aided design, as well as product design, development, engineering, and manufacturing services. Kelyniam Global, Inc. serves clients in various industries, including medical, automotive, aerospace, jewelry, nautical, and consumer products. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December, 2007. Kelyniam Global, Inc. was founded in 2005 and is based in Canton, Connecticut.

kelyniam global inc (KLYG) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kelyniam global inc (KLYG) Key Developments

Kelyniam Global, Inc. Announces Board Changes; Reports Earnings Results for the First Quarter of 2014

Kelyniam Global, Inc. announced that the board has appointed Dr. Mark Smith, a prominent Nuerosurgeon, and Dr. Naveh Levy, a practicing Diagnostic Radiologist, to the board of directors. Mark V Smith, M.D. is a neurosurgeon with over 20 years of clinical experience. The company reported earnings results for the first quarter of 2014. For the quarter, the company generated net income of $71,205. Compared with first quarter 2013, net sales increased 23% from $437,415 to $540,286, as a result of increased market penetration, gross profit moved up from $229,027 to $269,788, and net income swung from a loss of $17,272 to a profit of $71,205.

Kelyniam Global Inc. Reports Preliminary Revenues Results for the Year 2013

Kelyniam Global Inc. announced preliminary revenue of $1,857,516 for 2013. This represents an increase of 54% compared to sales of $1,206,227 in 2012.

Kelyniam Global Inc. Unveils Integrated Fixation System

Kelyniam Global, Inc. has introduced a new product to the marketplace, the 'IFS' (Integrated Fixation System) product. The product is patent pending and provides faster implantation, reduced hardware, cost savings and elimination of mundane tasks during the surgical procedure. The design team at Kelyniam created this product with the surgeons needs in mind together with the realization of economic sensitivities by the hospitals. They carefully collected feedback and input from a multitude of surgeons and designed the product to make their surgeries more efficient. Kelyniam will be unveiling the new product at the 82nd Annual AANS (American Association of Neurological Surgeons) meeting April 5-9, 2014 in San Francisco.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KLYG:US $0.16 USD -0.0258

KLYG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KLYG.
View Industry Companies
 

Industry Analysis

KLYG

Industry Average

Valuation KLYG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KELYNIAM GLOBAL INC, please visit www.kelyniam.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.